2017-03-23,John A. Orwin Joins Retrophin Board Of Directors
2017-03-21,RSI Alert: Retrophin (RTRX) Now Oversold
2017-03-07,Retrophin To Present At The Barclays Global Healthcare Conference
2017-03-01,Retrophin Provides Sparsentan Regulatory Update; Reports Fourth Quarter And Full Year 2016 Financial Results
2017-02-15,Retrophin To Report Fourth Quarter And Full Year 2016 Financial Results
2017-02-13,Retrophin Appoints William Rote Senior Vice President, Research And Development
2017-01-09,First Week of RTRX February 17th Options Trading
2017-01-09,Retrophin Provides Corporate Update And 2017 Preview
2017-01-04,Retrophin Appoints Elizabeth Reed General Counsel
2016-12-29,Retrophin To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-11-30,Retrophin To Present At The BMO Capital Markets Healthcare Conference
2016-11-19,Retrophin Reports Additional Positive Data From Phase 2 DUET Study Of Sparsentan In Focal Segmental Glomerulosclerosis At ASN Kidney Week 2016
2016-11-14,RTRX January 2019 Options Begin Trading
2016-11-10,Retrophin Reaches Agreement With FDA Under Special Protocol Assessment For Pivotal Trial Evaluating RE-024 In PKAN
2016-11-08,Retrophin Becomes Oversold (RTRX)
2016-11-07,Ratings Changes Today
2016-11-03,Retrophin Reports Third Quarter 2016 Financial Results
2016-10-21,Retrophin To Present Additional Data From Phase 2 DUET Study Of Sparsentan In Late-Breaking Oral Session At ASN Kidney Week 2016
2016-10-20,Retrophin To Report Third Quarter 2016 Financial Results
2016-10-06,Dr. Alvin Shih Departing Retrophin To Lead Biotechnology Start-Up
2016-09-30,Retrophin Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2016-09-22,Health Care Stocks Bound for Declines After 2016 Election
2016-09-14,Retrophin To Present At The Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series
2016-09-07,Retrophin Announces Positive Results for Kidney Disease Drug
2016-09-07,Retrophin (RTRX) Stock Price Target Upped at Leerink on Kidney Drug Trial
2016-09-07,Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
2016-09-07,Retrophin Announces Positive Top-Line Results From Phase 2 DUET Study Of Sparsentan In Patients With Focal Segmental Glomerulosclerosis
2016-08-30,Big Pharma's Punishment in Court of Public Opinion
2016-08-15,Retrophin Appoints Neil McFarlane Chief Operating Officer
2016-08-04,Retrophin Reports Second Quarter 2016 Financial Results
2016-07-21,Retrophin To Report Second Quarter 2016 Financial Results
2016-07-19,Retrophin Appoints Roy D. Baynes, M.D., Ph.D., To Board Of Directors
2016-07-18,Retrophin (RTRX) Weak On High Volume Today
2016-06-23,Retrophin Announces New Data From Physician-Initiated Treatment With RE-024 At The 20th International Congress Of Parkinson's Disease And Movement Disorders
2016-06-22,First Week of August 19th Options Trading For Retrophin (RTRX)
2016-06-22,Retrophin (RTRX) Is Today's Strong On High Volume Stock
2016-06-20,Retrophin Acquires Liquid Formulation Of Ursodeoxycholic Acid
2016-06-20,Notable Monday Option Activity: RTRX, TPX, ENOC
2016-06-20,Commit To Purchase Retrophin At $10, Earn 14% Using Options
2016-05-26,Retrophin To Present At Upcoming Investor Conferences
2016-05-05,Today's Weak On High Volume Stock: Retrophin (RTRX)
2016-05-04,Notable Wednesday Option Activity: RTRX, CONN, RMTI
2016-05-04,Retrophin (RTRX) Flagged As Strong On High Volume
2016-05-03,Retrophin Reports First Quarter 2016 Financial Results
2016-04-21,Retrophin To Present At The Deutsche Bank 41st Annual Health Care Conference
2016-04-19,Retrophin To Report First Quarter 2016 Financial Results
2016-04-04,Retrophin Names Gary A. Lyons Chairman Of The Board Of Directors
2016-03-30,Retrophin Completes Enrollment Of Phase 2 DUET Study Of Sparsentan In Focal Segmental Glomerulosclerosis
2016-03-24,Retrophin Announces Acceptance Of Four RE-024 Abstracts For Presentation At The 20th International Congress Of Parkinson's Disease And Movement Disorders
2016-03-22,First Week Of RTRX May 20th Options Trading
2016-03-09,Retrophin Announces New Data Supporting Further Clinical Development Of RE-024 For PKAN At The 2016 American College Of Medical Genetics And Genomics Annual Clinical Genetics Meeting
2016-03-08,Insider Trading Alert - RTRX, SWK And CVGI Traded By Insiders
2016-03-03,Retrophin To Present At The Barclays Global Healthcare Conference
2016-02-29,Ratings Changes Today
2016-02-25,Retrophin Reports Fourth Quarter And Full Year 2015 Financial Results
2016-02-25,Feb. 25 Premarket Briefing: 10 Things You Should Know
2016-02-24,Retrophin Receives European Orphan Drug Designation For RE-024 For The Treatment Of Pantothenate Kinase-Associated Neurodegeneration
2016-02-23,Retrophin To Present At The Cowen And Company 36th Annual Health Care Conference
2016-02-11,Retrophin To Report Fourth Quarter And Full Year 2015 Financial Results
2016-02-10,Statement On Imprimis Pharmaceuticals' Announcement Regarding ThiolaÂ®
2016-02-08,Retrophin is Now Oversold (RTRX)
2016-02-02,Retrophin (RTRX) Weak On High Volume
2016-01-29,KaloBios Distances Itself From Ex-CEO Martin Shkreli, Wants to Pay Employee Bonuses
2016-01-27,Retrophin To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-01-25,First Week of September 16th Options Trading For Retrophin (RTRX)
2016-01-21,With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'
2016-01-21,Despite Shkreli Drama, Retrophin Looks Interesting Now
2016-01-11,Commit To Buy Retrophin At $12.50, Earn 16% Using Options
2016-01-11,Retrophin Announces Preliminary Full-Year 2015 Revenue Of Approximately $99.9 Million
2015-12-30,Dec. 30 Premarket Briefing: 10 Things You Should Know
2015-12-20,Shkreli 'Was Running Turing Like a Hedge Fund'
2015-12-18,Notable Friday Option Activity: RTRX, BBW, MESG
2015-12-17,Retrophin Statement On Indictment Of Martin Shkreli
2015-12-17,Shkreli Arrest Won't Stop Drug Price Debate but Could Kill KaloBios
2015-11-18,Portfolio adjustments in a turbulent market
2015-11-16,Retrophin Receives European Orphan Drug Designation For Sparsentan For The Treatment Of Focal Segmental Glomerulosclerosis
2015-11-05,Retrophin (RTRX) Is Today's Dead Cat Bounce Stock
2015-11-05,Retrophin Announces Research Collaboration With The Grace Wilsey Foundation And The Warren Family Research Center For Drug Discovery And Development At The University Of Notre Dame
2015-11-04,Today's Weak On High Volume Stock: Retrophin (RTRX)
2015-11-04,Retrophin Sinks, Pharma Group Swings Back As Pricing Fight Escalates
2015-11-03,Retrophin Reports Third Quarter 2015 Financial Results
2015-11-03,Retrophin (RTRX) Showing Signs Of Perilous Reversal Today
2015-11-02,Strong On High Relative Volume: Retrophin (RTRX)
2015-10-20,Retrophin To Report Third Quarter 2015 Financial Results
2015-10-09,Insider Trading Alert - JASN, RTRX And RST Traded By Insiders
2015-09-24,Retrophin (RTRX) In A Perilous Reversal
2015-09-23,Retrophin (RTRX) Marked As A Dead Cat Bounce Stock
2015-09-22,Relative Strength Alert For Retrophin
2015-09-16,Retrophin To Present At The Leerink Partners 4th Annual Rare Disease Roundtable
2015-09-16,Retrophin (RTRX) Weak On High Volume
2015-09-04,Today's Dead Cat Bounce Stock Is Retrophin (RTRX)
2015-09-03,Stock To Watch: Retrophin (RTRX) In Perilous Reversal
2015-08-28,First Week of October 16th Options Trading For Retrophin (RTRX)
2015-08-06,Retrophin (RTRX) Highlighted As Today's Perilous Reversal Stock
2015-08-04,Retrophin Reports Second Quarter 2015 Financial Results
2015-08-03,Retrophin (RTRX) Strong On High Relative Volume Today
2015-07-21,Retrophin To Report Second Quarter 2015 Financial Results
2015-07-06,Retrophin Closes Sale Of Priority Review Voucher
2015-07-01,10 Best Biotech Stocks in the NASDAQ
2015-07-01,Insider Trading Alert - RTRX, SCOR And SMLP Traded By Insiders
2015-06-19,New Lifetime High For Retrophin (RTRX)
2015-06-09,Retrophin's Record Asset Sales Enhance Outlook
2015-06-03,Where the Money Was Made the Last 5 Years
2015-06-01,Today Retrophin (RTRX) Hits New Lifetime High
2015-05-28,Weak On High Volume: Retrophin (RTRX)
2015-05-27,Heavy Trading On Retrophin (RTRX) Before Market Open
2015-05-27,Retrophin Agrees To Sell Priority Review Voucher To Sanofi
2015-05-21,RTRX: Insiders Vs. Shorts
2015-05-20,Retrophin To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-18,Strong And Under The Radar: Retrophin (RTRX)
2015-05-15,Ratings Changes Today
2015-05-11,Retrophin Reports First Quarter 2015 Financial Results
2015-05-05,Retrophin Receives FDA Orphan Drug Designation For RE-024 For The Treatment Of Pantothenate Kinase-Associated Neurodegeneration
2015-04-30,Retrophin Announces FDA Review Of IND For RE-024 And Clearance To Proceed With Phase 1 Clinical Study In Healthy Adult Volunteers
2015-04-27,Retrophin To Report First Quarter 2015 Financial Results
2015-04-23,Technicals Flash Mixed Messages
2015-04-17,Why I'm Bullish On Biotech Firm Retrophin
2015-04-14,Retrophin Stock Sees Short Interest Decrease By 14.5%
2015-04-01,Retrophin's Board Of Directors Appoints John W. Kozarich, Ph.D. As Independent Director And Names Jeffrey A. Meckler As Chairman
2015-03-24,Retrophin Closes Public Offering Of 7,866,000 Shares Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
2015-03-24,Insiders Were Right: RTRX Makes New 52-Week High
2015-03-19,Retrophin (RTRX) Stock Rises Today After Pricing Public Offering of Common Stock
2015-03-19,Retrophin Prices Public Offering Of 6,840,000 Shares Of Common Stock
2015-03-18,U.S. Food And Drug Administration Approves Cholbam For The Treatment Of Rare Bile Acid Synthesis Disorders And Grants Rare Pediatric Disease Priority Review Voucher
2015-03-16,Retrophin Announces Proposed Public Offering Of 5,100,000 Shares Of Common Stock
2015-03-05,Retrophin Reports Fourth Quarter And Full Year 2014 Financial Results
2015-03-04,Tim Coughlin Joins Retrophin's Board Of Directors
2015-02-24,Launch Of Turing Pharmaceuticals Announced - New Drug Company To Focus On Treating Unmet Medical Needs Across Broad Therapeutic Areas
2015-02-19,Retrophin To Report Fourth Quarter And Full Year 2014 Financial Results
2015-02-19,RTRX: Insiders Vs. Shorts
2015-02-05,Retrophin To Present At The 2015 Leerink Global Healthcare Conference
2015-02-03,Retrophin Announces Voting Results Of Special Meeting Of Stockholders
2015-01-13,Short Interest In Retrophin Falls 15.4%
2015-01-12,Retrophin Announces Acquisition Of Exclusive Right To Purchase Cholic Acid From Asklepion Pharmaceuticals
2015-01-09,Ryan & Maniskas, LLP Announces Investigation Of Retrophin, Inc.
2015-01-09,Ligand Partner Retrophin Receives Orphan Drug Designation For Sparsentan
2015-01-09,Retrophin Provides Corporate Update
2015-01-08,Updated: Harwood Feffer LLP Announces Investigation Of Retrophin, Inc.
2015-01-06,Retrophin Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2014-12-18,The Winners for Best and Worst Biotech CEOs of 2014 Are...
2014-12-16,Retrophin Announces Addition To The NASDAQ Biotechnology Index
2014-12-15,Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ...
2014-12-12,INVESTOR ALERT: Class Action Lawsuit Against Retrophin, Inc. Announced By Law Offices Of Howard G. Smith
2014-12-12,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against Retrophin, Inc. And Lead Plaintiff Deadline Of December 19, 2014
2014-12-11,SHAREHOLDER ALERT: Investigation On Behalf Of Retrophin, Inc. Investors Announced By Law Offices Of Howard G. Smith
2014-12-01,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Retrophin, Inc. To Contact Brower Piven Before The December 19, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
2014-12-01,UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors Of Class Action Against Retrophin, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of December 19, 2014 -- RTRX
2014-11-25,Ousted Retrophin CEO Sold Stock While Urging Investors to Buy
2014-11-24,UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors Of Class Action Against Retrophin, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of December 19, 2014
2014-11-20,RTRX: Insiders Vs. Shorts
2014-11-19,Retrophin Names Margaret Valeur-Jensen, Ph.D. As General Counsel
2014-11-18,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against Retrophin, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of December 19, 2014 -- RTRX
2014-11-17,Retrophin Names Laura M. Clague As Chief Financial Officer
2014-11-13,Retrophin Reports Third Quarter 2014 Financial Results
2014-11-10,Retrophin Announces Appointment Of Stephen Aselage As Chief Executive Officer
2014-11-07,Retrophin Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors
2014-11-05,Lifshitz & Miller Law Firm Announces Investigation Of AmREIT, Inc., Digital River, Inc., Greater Sacramento Bancorp., Hampden Bancorp, Inc., Integrity Bancshares, Inc., Retrophin, Inc. And Sapient Corp.
2014-11-03,Super Important Biotech and Drug Stock Events for November
2014-10-31,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Retrophin, Inc. To Contact Brower Piven Before The December 19, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
2014-10-30,Retrophin To Report Third Quarter 2014 Financial Results
2014-10-22,Harwood Feffer LLP Announces Investigation Of Retrophin, Inc.
2014-10-21,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Retrophin, Inc. (RTRX) To Contact The Firm
2014-10-14,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Retrophin, Inc.
2014-10-14,Retrophin Announces Divestment Of Non-Core Assets To Turing Pharmaceuticals
2014-10-10,Retrophin Announces Appointment Of Jeffrey A. Meckler To Board Of Directors
2014-10-09,Retrophin Announces Appointment Of Gary Lyons To Board Of Directors
2014-10-03,Retrophin Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2014-09-30,Shkreli's Inability to Focus, Immaturity Cost Him Retrophin CEO Job
2014-09-30,Retrophin Announces Leadership Reorganization
2014-09-30,RSI Alert: Retrophin (RTRX) Now Oversold
2014-09-30,Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug
2014-09-24,5 Stocks Insiders Love Right Now
2014-09-17,Harwood Feffer LLP Announces Investigation Of Retrophin, Inc.
2014-09-17,INVESTOR ALERT: Investigation On Behalf Of Retrophin, Inc. Shareholders Announced By Glancy Binkow & Goldberg LLP
2014-09-17,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Retrophin, Inc.
2014-09-17,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Retrophin, Inc. - RTRX
2014-09-16,Retrophin Announces Changes To Board Of Directors And Management Team
2014-09-10,Retrophin Assailed for 'Exorbitant' Price Hike
2014-08-12,Retrophin Reports Second Quarter 2014 Financial Results
2014-08-11,Retrophin CEO Under Fire for Twitter Faux Pas
